nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—SLC22A2—Cladribine—multiple sclerosis	0.415	0.535	CbGbCtD
Tubocurarine—SLC22A1—Cladribine—multiple sclerosis	0.361	0.465	CbGbCtD
Tubocurarine—HTR3A—area postrema—multiple sclerosis	0.0947	0.507	CbGeAlD
Tubocurarine—HTR3A—nerve—multiple sclerosis	0.0123	0.0659	CbGeAlD
Tubocurarine—HTR3A—brainstem—multiple sclerosis	0.00529	0.0283	CbGeAlD
Tubocurarine—CHRNB1—medulla oblongata—multiple sclerosis	0.0048	0.0257	CbGeAlD
Tubocurarine—CHRNB1—midbrain—multiple sclerosis	0.00439	0.0235	CbGeAlD
Tubocurarine—CHRNB1—spinal cord—multiple sclerosis	0.00428	0.0229	CbGeAlD
Tubocurarine—ACHE—medulla oblongata—multiple sclerosis	0.00416	0.0223	CbGeAlD
Tubocurarine—CHRNA2—nervous system—multiple sclerosis	0.00388	0.0208	CbGeAlD
Tubocurarine—ACHE—midbrain—multiple sclerosis	0.00381	0.0204	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—multiple sclerosis	0.00373	0.02	CbGeAlD
Tubocurarine—ACHE—spinal cord—multiple sclerosis	0.00371	0.0199	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—multiple sclerosis	0.00365	0.0195	CbGeAlD
Tubocurarine—CHRNA1—brain—multiple sclerosis	0.00357	0.0191	CbGeAlD
Tubocurarine—CHRNB1—cerebellum—multiple sclerosis	0.0034	0.0182	CbGeAlD
Tubocurarine—CHRNA2—brain—multiple sclerosis	0.00296	0.0159	CbGeAlD
Tubocurarine—ACHE—cerebellum—multiple sclerosis	0.00294	0.0158	CbGeAlD
Tubocurarine—HTR3A—nervous system—multiple sclerosis	0.00277	0.0148	CbGeAlD
Tubocurarine—CHRNB1—brain—multiple sclerosis	0.00276	0.0148	CbGeAlD
Tubocurarine—HTR3A—central nervous system—multiple sclerosis	0.00267	0.0143	CbGeAlD
Tubocurarine—ACHE—brain—multiple sclerosis	0.00239	0.0128	CbGeAlD
Tubocurarine—CHRM2—nervous system—multiple sclerosis	0.00231	0.0124	CbGeAlD
Tubocurarine—SLC22A1—nervous system—multiple sclerosis	0.00227	0.0122	CbGeAlD
Tubocurarine—CHRM2—central nervous system—multiple sclerosis	0.00223	0.0119	CbGeAlD
Tubocurarine—SLC22A1—central nervous system—multiple sclerosis	0.00219	0.0117	CbGeAlD
Tubocurarine—HTR3A—brain—multiple sclerosis	0.00212	0.0113	CbGeAlD
Tubocurarine—CHRM2—brain—multiple sclerosis	0.00177	0.00946	CbGeAlD
Tubocurarine—SLC22A1—brain—multiple sclerosis	0.00174	0.00929	CbGeAlD
Tubocurarine—ACHE—ATF-2 transcription factor network—SELE—multiple sclerosis	0.00054	0.0145	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000512	0.0138	CbGpPWpGaD
Tubocurarine—ACHE—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000434	0.0117	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—S1PR1—multiple sclerosis	0.000424	0.0114	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—KCNA3—multiple sclerosis	0.000421	0.0113	CbGpPWpGaD
Tubocurarine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00041	0.011	CbGpPWpGaD
Tubocurarine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000382	0.0103	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—KCNA3—multiple sclerosis	0.000335	0.00901	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—KCNA3—multiple sclerosis	0.000312	0.0084	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000308	0.00829	CbGpPWpGaD
Tubocurarine—ACHE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000305	0.00821	CbGpPWpGaD
Tubocurarine—CHRNA1—ErbB2/ErbB3 signaling events—STAT3—multiple sclerosis	0.000299	0.00805	CbGpPWpGaD
Tubocurarine—ACHE—Glycerophospholipid biosynthesis—BCHE—multiple sclerosis	0.000297	0.00799	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000289	0.00776	CbGpPWpGaD
Tubocurarine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000286	0.0077	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000278	0.00748	CbGpPWpGaD
Tubocurarine—CHRNA1—ErbB2/ErbB3 signaling events—MAPK1—multiple sclerosis	0.000272	0.00732	CbGpPWpGaD
Tubocurarine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000267	0.00718	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000265	0.00713	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000262	0.00705	CbGpPWpGaD
Tubocurarine—ACHE—Monoamine Transport—IL1B—multiple sclerosis	0.000256	0.00688	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000253	0.0068	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000249	0.0067	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000249	0.00669	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000246	0.00661	CbGpPWpGaD
Tubocurarine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000243	0.00654	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—BCHE—multiple sclerosis	0.000236	0.00635	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000229	0.00616	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000219	0.00588	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—BCHE—multiple sclerosis	0.000207	0.00557	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—CXCR3—multiple sclerosis	0.000207	0.00557	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—BCHE—multiple sclerosis	0.000201	0.0054	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000199	0.00534	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—BCHE—multiple sclerosis	0.000191	0.00513	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000189	0.00508	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000186	0.00501	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—CNR1—multiple sclerosis	0.000186	0.005	CbGpPWpGaD
Tubocurarine—ACHE—Monoamine Transport—TNF—multiple sclerosis	0.000186	0.00499	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000176	0.00473	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000174	0.00467	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000173	0.00465	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000169	0.00454	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000158	0.00425	CbGpPWpGaD
Tubocurarine—ACHE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000158	0.00424	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000154	0.00414	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000153	0.00412	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000153	0.00412	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000153	0.00411	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000152	0.0041	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000149	0.004	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000146	0.00394	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000146	0.00394	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000136	0.00365	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000133	0.00357	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00013	0.0035	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Other—CCR5—multiple sclerosis	0.00013	0.00349	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000127	0.00342	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000125	0.00336	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000123	0.0033	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000122	0.00329	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000121	0.00326	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—S1PR1—multiple sclerosis	0.00012	0.00323	CbGpPWpGaD
Tubocurarine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.00012	0.00322	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.00012	0.00321	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—BCHE—multiple sclerosis	0.000118	0.00317	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000116	0.00313	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000116	0.00313	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000116	0.00313	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000114	0.00308	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000108	0.0029	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000105	0.00282	CbGpPWpGaD
Tubocurarine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000102	0.00274	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	9.77e-05	0.00263	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CXCR3—multiple sclerosis	9.7e-05	0.00261	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—GPR65—multiple sclerosis	9.69e-05	0.00261	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SRM—multiple sclerosis	9.69e-05	0.00261	CbGpPWpGaD
Tubocurarine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.68e-05	0.0026	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	9.63e-05	0.00259	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.47e-05	0.00255	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CCR2—multiple sclerosis	9.44e-05	0.00254	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—BCHE—multiple sclerosis	9.4e-05	0.00253	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	9.33e-05	0.00251	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	9.32e-05	0.00251	CbGpPWpGaD
Tubocurarine—ACHE—ATF-2 transcription factor network—IL6—multiple sclerosis	9.18e-05	0.00247	CbGpPWpGaD
Tubocurarine—CHRND—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	9.01e-05	0.00242	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	9e-05	0.00242	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL13—multiple sclerosis	8.87e-05	0.00238	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCR1—multiple sclerosis	8.87e-05	0.00238	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.82e-05	0.00237	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—BCHE—multiple sclerosis	8.76e-05	0.00236	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	8.76e-05	0.00235	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	8.73e-05	0.00235	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CNR1—multiple sclerosis	8.71e-05	0.00234	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	8.3e-05	0.00223	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	8.08e-05	0.00217	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.99e-05	0.00215	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	7.88e-05	0.00212	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CXCL10—multiple sclerosis	7.84e-05	0.00211	CbGpPWpGaD
Tubocurarine—HTR3A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.77e-05	0.00209	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SRM—multiple sclerosis	7.72e-05	0.00208	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.71e-05	0.00207	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.66e-05	0.00206	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.5e-05	0.00202	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.48e-05	0.00201	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.28e-05	0.00196	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SRM—multiple sclerosis	7.19e-05	0.00193	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.97e-05	0.00188	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.92e-05	0.00186	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—MAPK1—multiple sclerosis	6.9e-05	0.00186	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP24A1—multiple sclerosis	6.83e-05	0.00184	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP27B1—multiple sclerosis	6.83e-05	0.00184	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—S1PR1—multiple sclerosis	6.8e-05	0.00183	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CCL5—multiple sclerosis	6.75e-05	0.00181	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.67e-05	0.00179	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.61e-05	0.00178	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCL3—multiple sclerosis	6.32e-05	0.0017	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GPC5—multiple sclerosis	6.24e-05	0.00168	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	6.23e-05	0.00168	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	6.17e-05	0.00166	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.17e-05	0.00166	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	6.08e-05	0.00164	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	6.08e-05	0.00164	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	5.87e-05	0.00158	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—MAPK1—multiple sclerosis	5.87e-05	0.00158	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	5.78e-05	0.00155	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	5.76e-05	0.00155	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	5.71e-05	0.00154	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	5.64e-05	0.00152	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—MAPK1—multiple sclerosis	5.57e-05	0.0015	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.51e-05	0.00148	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	5.48e-05	0.00147	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	5.44e-05	0.00146	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	5.44e-05	0.00146	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.37e-05	0.00144	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	5.27e-05	0.00142	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	5.25e-05	0.00141	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—RRM1—multiple sclerosis	5.17e-05	0.00139	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	5.07e-05	0.00136	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	5.07e-05	0.00136	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	5.01e-05	0.00135	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	5.01e-05	0.00135	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	4.97e-05	0.00134	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GPC5—multiple sclerosis	4.97e-05	0.00134	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.89e-05	0.00132	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.83e-05	0.0013	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	4.81e-05	0.00129	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.77e-05	0.00128	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.76e-05	0.00128	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	4.75e-05	0.00128	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	4.75e-05	0.00128	CbGpPWpGaD
Tubocurarine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.69e-05	0.00126	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.67e-05	0.00126	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GPC5—multiple sclerosis	4.64e-05	0.00125	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	4.55e-05	0.00122	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	4.55e-05	0.00122	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.5e-05	0.00121	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.45e-05	0.0012	CbGpPWpGaD
Tubocurarine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.37e-05	0.00117	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	4.17e-05	0.00112	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—RRM1—multiple sclerosis	4.12e-05	0.00111	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	4.09e-05	0.0011	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.01e-05	0.00108	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	3.87e-05	0.00104	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—RRM1—multiple sclerosis	3.84e-05	0.00103	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.78e-05	0.00102	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.7e-05	0.000994	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	3.68e-05	0.00099	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	3.65e-05	0.00098	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.59e-05	0.000964	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.55e-05	0.000955	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	3.55e-05	0.000954	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—MAPK1—multiple sclerosis	3.45e-05	0.000927	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.45e-05	0.000927	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	3.44e-05	0.000924	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.34e-05	0.000899	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.32e-05	0.000892	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	3.24e-05	0.000872	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	3.23e-05	0.000868	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.14e-05	0.000845	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	3.12e-05	0.000839	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	3.1e-05	0.000834	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	3.01e-05	0.00081	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	2.98e-05	0.000801	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—POMC—multiple sclerosis	2.98e-05	0.000801	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—BCHE—multiple sclerosis	2.97e-05	0.000799	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	2.94e-05	0.00079	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	2.93e-05	0.000788	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	2.91e-05	0.000784	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	2.88e-05	0.000774	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.87e-05	0.000771	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	2.82e-05	0.000757	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	2.75e-05	0.000739	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	2.71e-05	0.000728	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	2.69e-05	0.000723	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	2.69e-05	0.000723	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	2.68e-05	0.000721	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	2.56e-05	0.000689	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	2.44e-05	0.000655	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.38e-05	0.00064	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—BCHE—multiple sclerosis	2.37e-05	0.000637	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	2.31e-05	0.000621	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.22e-05	0.000597	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—BCHE—multiple sclerosis	2.21e-05	0.000593	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	2.1e-05	0.000564	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.08e-05	0.000559	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.05e-05	0.000551	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.92e-05	0.000515	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.89e-05	0.000508	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.86e-05	0.000501	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.84e-05	0.000496	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.82e-05	0.000488	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOE—multiple sclerosis	1.79e-05	0.000481	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.78e-05	0.000479	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.76e-05	0.000474	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.73e-05	0.000466	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.63e-05	0.000437	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.6e-05	0.00043	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—POMC—multiple sclerosis	1.54e-05	0.000413	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.48e-05	0.000397	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1.44e-05	0.000388	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1.44e-05	0.000387	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOE—multiple sclerosis	1.42e-05	0.000383	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ALB—multiple sclerosis	1.4e-05	0.000376	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOE—multiple sclerosis	1.33e-05	0.000357	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.31e-05	0.000353	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.26e-05	0.000338	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.24e-05	0.000333	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—POMC—multiple sclerosis	1.22e-05	0.000329	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.2e-05	0.000323	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.15e-05	0.000309	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—POMC—multiple sclerosis	1.14e-05	0.000307	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.12e-05	0.0003	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ALB—multiple sclerosis	1.12e-05	0.0003	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.1e-05	0.000296	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.09e-05	0.000294	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ALB—multiple sclerosis	1.04e-05	0.00028	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.02e-05	0.000273	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	9.18e-06	0.000247	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	8.72e-06	0.000235	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	8.53e-06	0.000229	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	8.35e-06	0.000225	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	7.75e-06	0.000208	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	6.45e-06	0.000173	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	6.42e-06	0.000173	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	6.1e-06	0.000164	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	5.43e-06	0.000146	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	5.04e-06	0.000136	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	5.03e-06	0.000135	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.93e-06	0.000133	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.79e-06	0.000102	CbGpPWpGaD
